USP and cGMP compounding compliance standards — ACE evaluation framework

Compounding Compliance
Standards

ACE evaluations are aligned with USP chapters 795, 797, and 800, cGMP principles, and the operational domains FDA actually examines — not a generic pharmacy accreditation model.

Industry Standards Supporting Certification

Modern compounding environments operate within complex regulatory expectations designed to protect patient safety and ensure consistent medication quality. ACE certification evaluates operational systems against recognized compounding and manufacturing standards used throughout healthcare.

USP <795>

Non-sterile compounding standards governing formulation practices, documentation, and preparation environments.

USP <797>

Sterile compounding requirements addressing aseptic technique, environmental monitoring, and contamination prevention.

USP <800>

Hazardous drug handling protections supporting staff safety and environmental containment.

cGMP Principles

Quality system expectations commonly applied within FDA-registered outsourcing facilities operating under 503B regulations.

Operational Compliance Areas Evaluated

Core compliance systems reviewed during ACE certification
System Area Evaluation Focus
Environmental Monitoring Air quality controls and contamination prevention practices.
Personnel Training Competency validation and continuing qualification.
Documentation SOP governance and traceability.
Quality Systems Deviation handling, CAPA, and change control.
Facility Controls Cleanroom and workflow management practices.

Learn how evaluation occurs during our certification process.

Build Confidence Through Compliance

ACE helps organizations strengthen operational systems supporting long-term regulatory readiness and inspection performance.

Request Certification Consultation View Programs